Register now – Nov. 19, 2025: Regulatory compliance and recent policy changes at the federal and state levels relevant to hospital laboratory outreach programs.

Launch or refresh your lab newsletter with five key steps to engage, inform, and build stronger connections with your audience.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss recent news about the use of artificial intelligence (AI) tools in healthcare.

Alice Gallo De Moraes, M.D., discusses why laboratory testing is important within her practice.

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., discuss the changing face of laboratory medicine in the time of COVID-19.

Jane Hermansen of Mayo Clinic Labs weighs in on a discussion of uses for expanded testing capacity after the pandemic is over.

This "Phlebotomy Webinar" will discuss the various types of swabs that can be used to collect specimens for SARS-CoV-2 molecular testing.

A supervisor in the lab that's at the heart of Mayo Clinic Laboratories' COVID-19 testing, Dave Majewski's job has changed dramatically in the last year, as he went from overseeing about 40 staff members to more than 240 in a lab that now runs 24/7.

Andrew McKeon, M,B., B.Ch., M.D., provides an overview of Mayo Clinic Laboratories' new paraneoplastic vision loss evaluation — a test that can help direct a cancer diagnosis and guide treatment. He reviews why this test was developed, when it should be ordered, and how the results can affect patient care.

This week’s research roundup features a study on trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

In January, Mayo Clinic Laboratories announced a new test along with numerous reference value changes, obsolete tests, and algorithm changes.

An article authored by Jane Hermansen of Mayo Clinic Labs considers how the experiences of the pandemic will shape the lab industry in years to come.

This week’s research roundup features an expert review of the AGA clinical practice update on the management of refractory helicobacter pylori infection.

Matthew Binnicker, Ph.D., vice chair of practice for Mayo Clinic's Department of Laboratory Medicine and Pathology, joins William Morice II, M.D., Ph.D., president of Mayo Clinic Laboratories, for this week's "Answers From the Lab" leadership update. In this episode, Dr. Binnicker and Dr. Morice discuss the impact that emerging COVID-19 variants could have on virus testing, vaccine and spread.

A genetic counselor with Mayo Clinic Laboratories for the last 15 years, Cassie Runke relishes her role serving as a resource for health care providers who are looking to help their patients find answers through genetic testing.